EQL Pharma AB
EQL | ST
Overview
Corporate Details
- ISIN(s):
- SE0005497732
- LEI:
- 549300Q8B2D2AE8GCW21
- Country:
- Sweden
- Address:
- Stortorget 1, 222 23 Lund
- Website:
- https://eqlpharma.com/en/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
EQL Pharma AB is a pharmaceutical company specializing in the development, marketing, and sale of cost-efficient medicines. The company's strategy focuses on niche generics—pharmaceuticals with expired patent protection and limited market competition. Its portfolio also includes specialty pharmaceuticals and parallel imported medicines, alongside products like rapid antigen tests. EQL Pharma primarily serves pharmacies and hospitals within the Nordic region and select European markets. The company emphasizes operational simplicity and efficiency, collaborating with a network of development partners in Asia and Europe to maintain an extensive product pipeline.
Stop Scraping. Start Analyzing.
You're viewing a fraction of the data available for EQL Pharma AB.
Get complete, real-time, and AI-ready data via the API the pros use.
Filings
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-08-21 18:00 |
Post-Annual General Meeting Information
Kommuniké från årsstämma i EQL Pharma AB den 21 augusti 2025
|
Swedish | 258.1 KB | |
| 2025-08-21 18:00 |
Post-Annual General Meeting Information
Bulletin from the annual general meeting in EQL Pharma AB on 21 August 2025
|
English | 259.5 KB | |
| 2025-08-18 11:00 |
Board/Management Information
Valberedningens förslag inför årsstämman i EQL Pharma AB
|
Swedish | 322.2 KB | |
| 2025-08-18 11:00 |
Board/Management Information
The Nomination Committee’s proposal for the annual general meeting in EQL Pharm…
|
English | 321.4 KB | |
| 2025-08-08 07:00 |
Earnings Release
|
Swedish | 1.2 MB | |
| 2025-08-08 07:00 |
Quarterly Report
|
English | 1.3 MB | |
| 2025-07-22 10:00 |
Pre-Annual General Meeting Information
Kallelse till årsstämma i EQL Pharma AB
|
Swedish | 281.5 KB | |
| 2025-07-22 10:00 |
Pre-Annual General Meeting Information
Notice of annual general meeting in EQL Pharma AB
|
English | 287.5 KB | |
| 2025-05-08 07:00 |
Earnings Release
|
Swedish | 1.3 MB | |
| 2025-05-08 07:00 |
Earnings Release
|
English | 1.3 MB | |
| 2025-03-07 08:30 |
Report Publication Announcement
New financial targets for the period 2024/25 – 2028/29
|
English | 351.6 KB | |
| 2025-03-07 08:30 |
Earnings Release
Nya finansiella mål för perioden 2024/25 - 2028/29
|
Swedish | 291.7 KB | |
| 2025-02-24 09:24 |
Board/Management Information
Valberedning inför årsstämman 2025
|
Swedish | 352.0 KB | |
| 2025-02-24 09:24 |
Post-Annual General Meeting Information
Nomination committee for the 2025 Annual General Meeting
|
English | 216.8 KB | |
| 2025-02-05 07:00 |
Annual Report
|
Swedish | 1.3 MB |
Automate Your Workflow. Get a real-time feed of all EQL Pharma AB filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for EQL Pharma AB via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-02-17 | christer fåhraeus | Other | Sell | 100,000 | 8,620,000.00 SEK |
